{
    "filename": "22221751.2020.1723441.pdf",
    "content_type": "application/pdf",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.1080/22221751.2020.1723441",
            "url": "https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1723441?needAccess=true"
        },
        "title": "An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies",
        "date": 2020,
        "author": "Shibo Jiang, Lanying Du, Zhengli Shi",
        "affiliations": [
            "Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, People\u2019s Republic of China",
            "Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA",
            "Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA",
            "CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People\u2019s Republic of China"
        ],
        "journal": "Emerging Microbes & Infections",
        "volume": "9",
        "references": "@article{lu-a,\n  author = {Lu, H. and Stratton, C.W. and Tang, Y.W.},\n  title = {Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle},\n  journal = {J Med Virol},\n  volume = {2020},\n  doi = {DOI: 10.1002/jmv. 25678},\n  number = {92},\n  language = {}\n}\n@article{chan-a,\n  author = {Chan, J.F. and Kok, K.H. and Zhu, Z.},\n  title = {Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory disease in Wuhan, Hubei, China},\n  journal = {Emerg Microbes Infect},\n  volume = {2020},\n  pages = {221\u2013236},\n  more-authors = {true},\n  number = {9},\n  language = {}\n}\n@article{hu2018a,\n  author = {Hu, D. and Zhu, C. and Ai, L.},\n  title = {Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats},\n  journal = {Emerg Microbes Infect},\n  date = {2018},\n  volume = {7},\n  pages = {154},\n  more-authors = {true},\n  language = {}\n}\n@article{zhang-a,\n  author = {Zhang, N. and Wang, L. and Deng, X.},\n  title = {Recent advances in the detection of respiratory virus infection in humans},\n  journal = {J Med Virol},\n  volume = {2020},\n  doi = {DOI: 10.1002/jmv.25674},\n  more-authors = {true},\n  number = {92},\n  language = {}\n}\n@article{du2009a,\n  author = {Du, L. and He, Y. and Zhou, Y.},\n  title = {The spike protein of SARSCoV\u2014a target for vaccine and therapeutic development},\n  journal = {Nat Rev Microbiol},\n  date = {2009},\n  volume = {7},\n  pages = {226\u2013236},\n  more-authors = {true},\n  language = {}\n}\n@article{liu2004a,\n  author = {Liu, S. and Xiao, G. and Chen, Y.},\n  title = {Interaction between heptad repeat 1 and 2 regions in spike protein of SARSassociated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors},\n  journal = {Lancet},\n  date = {2004},\n  volume = {363},\n  pages = {938\u2013947},\n  more-authors = {true},\n  language = {}\n}\n@article{xia2019a,\n  author = {Xia, S. and Yan, L. and Xu, W.},\n  title = {A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike},\n  journal = {Sci Adv},\n  date = {2019},\n  volume = {5},\n  pages = {4580},\n  more-authors = {true},\n  language = {}\n}\n@misc{du2017a,\n  author = {Du, L. and Yang, Y. and Zhou, Y.},\n  title = {MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets},\n  date = {2017},\n  volume = {21},\n  pages = {131\u2013143},\n  more-authors = {true},\n  language = {}\n}\n@misc{zhou2019a,\n  author = {Zhou, Y. and Yang, Y. and Huang, J.},\n  title = {Advances in MERSCoV vaccines and therapeutics based on the receptor-binding domain. Viruses},\n  date = {2019},\n  volume = {11},\n  pages = {60},\n  more-authors = {true},\n  language = {}\n}\n@article{du2016a,\n  author = {Du, L. and Tai, W. and Yang, Y.},\n  title = {Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines},\n  journal = {Nat Commun},\n  date = {2016},\n  volume = {7},\n  pages = {13473},\n  more-authors = {true},\n  language = {}\n}\n@article{wang2015a,\n  author = {Wang, L. and Shi, W. and Joyce, M.G.},\n  title = {Evaluation of candidate vaccine approaches for MERS-CoV},\n  journal = {Nat Commun},\n  date = {2015},\n  volume = {6},\n  pages = {7712},\n  more-authors = {true},\n  language = {}\n}\n@article{chen2017a,\n  author = {Chen, Y. and Lu, S. and Jia, H.},\n  title = {A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein},\n  journal = {Emerg Microbes Infect},\n  date = {2017},\n  volume = {6},\n  pages = {37},\n  more-authors = {true},\n  language = {}\n}\n@article{zeng2017a,\n  author = {Zeng, L.P. and Ge, X.-Y. and Peng, C.},\n  title = {Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses},\n  journal = {Sci China Life Sci},\n  date = {2017},\n  volume = {60},\n  pages = {1399\u20131402},\n  more-authors = {true},\n  language = {}\n}\n",
        "links": [
            "http://dx.doi.org/10.1080/",
            "https://www.tandfonline.com/action/journalInformation?journalCode=temi20",
            "http://orcid.org/0000-0001-8283-7135",
            "http://orcid.org/0000-0001-5955-1294",
            "http://www.thatsmags.com/china/post/",
            "http://www.thatsmags.com/china/post/30618/newcoronavirus-spreads-to-over-130-in-china-death-tollrises",
            "https://apps.who.int/iris/bitstream/",
            "http://orcid.org/0000-0001-8089-163X"
        ],
        "emails": [
            "shibojiang@fudan.edu.cn"
        ],
        "pages": "275-277",
        "cited_by": 9,
        "references_ris": "TY  - JOUR\nAU  - Lu, H.\nAU  - Stratton, C.W.\nAU  - Tang, Y.W.\nTI  - Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle\nT2  - J Med Virol\nVL  - 2020\nDO  - 10.1002/jmv. 25678\nIS  - 92\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chan, J.F.\nAU  - Kok, K.H.\nAU  - Zhu, Z.\nTI  - Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory disease in Wuhan, Hubei, China\nT2  - Emerg Microbes Infect\nVL  - 2020\nSP  - 221\nEP  - 236\nC1  - true\nIS  - 9\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Hu, D.\nAU  - Zhu, C.\nAU  - Ai, L.\nTI  - Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats\nT2  - Emerg Microbes Infect\nPY  - 2018\nDA  - 2018\nVL  - 7\nSP  - 154\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zhang, N.\nAU  - Wang, L.\nAU  - Deng, X.\nTI  - Recent advances in the detection of respiratory virus infection in humans\nT2  - J Med Virol\nVL  - 2020\nDO  - 10.1002/jmv.25674\nC1  - true\nIS  - 92\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Du, L.\nAU  - He, Y.\nAU  - Zhou, Y.\nTI  - The spike protein of SARSCoV\u2014a target for vaccine and therapeutic development\nT2  - Nat Rev Microbiol\nPY  - 2009\nDA  - 2009\nVL  - 7\nSP  - 226\nEP  - 236\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Liu, S.\nAU  - Xiao, G.\nAU  - Chen, Y.\nTI  - Interaction between heptad repeat 1 and 2 regions in spike protein of SARSassociated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors\nT2  - Lancet\nPY  - 2004\nDA  - 2004\nVL  - 363\nSP  - 938\nEP  - 947\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Xia, S.\nAU  - Yan, L.\nAU  - Xu, W.\nTI  - A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike\nT2  - Sci Adv\nPY  - 2019\nDA  - 2019\nVL  - 5\nSP  - 4580\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Du, L.\nAU  - Yang, Y.\nAU  - Zhou, Y.\nTI  - MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets\nPY  - 2017\nDA  - 2017\nVL  - 21\nSP  - 131\nEP  - 143\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Zhou, Y.\nAU  - Yang, Y.\nAU  - Huang, J.\nTI  - Advances in MERSCoV vaccines and therapeutics based on the receptor-binding domain. Viruses\nPY  - 2019\nDA  - 2019\nVL  - 11\nSP  - 60\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Du, L.\nAU  - Tai, W.\nAU  - Yang, Y.\nTI  - Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines\nT2  - Nat Commun\nPY  - 2016\nDA  - 2016\nVL  - 7\nSP  - 13473\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wang, L.\nAU  - Shi, W.\nAU  - Joyce, M.G.\nTI  - Evaluation of candidate vaccine approaches for MERS-CoV\nT2  - Nat Commun\nPY  - 2015\nDA  - 2015\nVL  - 6\nSP  - 7712\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chen, Y.\nAU  - Lu, S.\nAU  - Jia, H.\nTI  - A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein\nT2  - Emerg Microbes Infect\nPY  - 2017\nDA  - 2017\nVL  - 6\nSP  - 37\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zeng, L.P.\nAU  - Ge, X.-Y.\nAU  - Peng, C.\nTI  - Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses\nT2  - Sci China Life Sci\nPY  - 2017\nDA  - 2017\nVL  - 60\nSP  - 1399\nEP  - 1402\nC1  - true\nLA  - \nER  - \n\n",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": [
            {
                "id": "1",
                "caption": "Analysis of the functional domains in 2019-nCoV spike protein and its gene. (A) Phylogenetic analysis of S gene of 2019nCoV (Wuhan-Hu-1), bat-SL-CoVZXC21, bat-SL-CoVZXC45, SARS-CoV and other coronaviruses using Neighbor-Joining method. (B) The representative scheme of functional domains in S protein of 2019-nCoV. SP, signal peptide; NTD, N-terminal domain; RBD, receptor-binding domain; FP, fusion peptide, HR1, heptad repeat 1; HR2, heptad repeat 2; TM, transmembrane domain; CP, cytoplasmic domain. (C) The target sites in 2019-nCoV S for development of vaccines, antibodies and fusion/entry inhibitors"
            }
        ],
        "figure_urls": [
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-000.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-001.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-002.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-004.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-006.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-010.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-012.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-016.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-020.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/22221751.2020.1723441/img-025.png"
        ]
    },
    "sections": {
        "acknowledgements": [
            "We thank Dr Ben Hu at Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China for phylogenetic analysis of 2019-nCoV S gene."
        ],
        "disclosures": [
            "<strong>Disclosure statement</strong><br/><br/>No potential conflict of interest was reported by the author(s)."
        ],
        "funding": [
            "This work was partially supported by the NIH R01AI139092 to L.D.  ORCID Shibo Jiang http://orcid.org/0000-0001-8283-7135 Lanying Du http://orcid.org/0000-0001-5955-1294 Zhengli Shi http://orcid.org/0000-0001-8089-163X"
        ],
        "introduction": [
            "An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies",
            "In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and some live animals, including poultry, bats, marmots and other wild animals, suggesting that the pathogen may be transmitted from an animal to human. The pathogen was soon identified to be a novel coronavirus, 2019nCoV denoted by WHO [<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>]."
        ]
    },
    "structured_content": {
        "Acknowledgements": [
            "We thank Dr Ben Hu at Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China for phylogenetic analysis of 2019-nCoV S gene."
        ],
        "Disclosure statement": [
            "No potential conflict of interest was reported by the author(s)."
        ],
        "Funding": [
            "This work was partially supported by the NIH R01AI139092 to L.D.",
            "Shibo Jiang http://orcid.org/0000-0001-8283-7135 Lanying Du http://orcid.org/0000-0001-5955-1294 Zhengli Shi http://orcid.org/0000-0001-8089-163X"
        ],
        "References": [
            "[<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>] Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92. DOI:10.1002/jmv. 25678",
            "[<a class=\"ref-link\" id=\"c2\" href=\"#r2\">2</a>] Chan JF, Kok KH, Zhu Z, et al Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory disease in",
            "Wuhan, Hubei, China. Emerg Microbes Infect. 2020;9:221\u2013236. [<a class=\"ref-link\" id=\"c3\" href=\"#r3\">3</a>] Hu D, Zhu C, Ai L, et al Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerg Microbes Infect. 2018;7:154. [<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>] Zhang N, Wang L, Deng X, et al Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92. DOI:10.1002/jmv.25674 [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>] Du L, He Y, Zhou Y, et al The spike protein of SARSCoV\u2014a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7:226\u2013236. [<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>] Liu S, Xiao G, Chen Y, et al Interaction between heptad repeat 1 and 2 regions in spike protein of SARSassociated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet. 2004;363:938\u2013947. [<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>] Xia S, Yan L, Xu W, et al A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019;5:eaav4580. [<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>] Du L, Yang Y, Zhou Y, et al MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets. 2017;21:131\u2013143. [<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] Zhou Y, Yang Y, Huang J, et al Advances in MERSCoV vaccines and therapeutics based on the receptor-binding domain. Viruses. 2019;11:pii: E60. [<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>] Du L, Tai W, Yang Y, et al Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines. Nat Commun. 2016;7:13473. [<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>] Wang L, Shi W, Joyce MG, et al Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6:7712. [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] Chen Y, Lu S, Jia H, et al A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017;6:e37. [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] Zeng LP, Ge X-Y, Peng C, et al Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. Sci China Life Sci. 2017;60:1399\u20131402."
        ]
    },
    "participants": [
        {
            "participant": "View citing articles",
            "number": 9,
            "context": "View Crossmark data. <mark class=\"stats\">Citing articles: 9 View citing articles</mark>. Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=temi20"
        },
        {
            "participant": "cases in the 25\u201389-year-old",
            "number": 198,
            "context": "The pathogen was soon identified to be a novel coronavirus, 2019nCoV denoted by WHO [<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>]. <mark class=\"stats\">On 19 January 2020, Wuhan Health Commission reported that a total 198 cases in the 25\u201389-year-old range were confirmed positive for 2019-nCoV, including 25 being discharged and 3 having died</mark>. Among the 170 patients under treatment in hospitals, 126, 35, and 9 are in mild, severe, and critical condition, respectively (http://www.thatsmags.com/china/post/30618/newcoronavirus-spreads-to-over-130-in-china-death-tollrises)"
        },
        {
            "participant": "patients",
            "number": 170,
            "context": "On 19 January 2020, Wuhan Health Commission reported that a total 198 cases in the 25\u201389-year-old range were confirmed positive for 2019-nCoV, including 25 being discharged and 3 having died. <mark class=\"stats\">Among the 170 patients under treatment in hospitals, 126, 35, and 9 are in mild, severe, and critical condition, respectively (http://www.thatsmags.com/china/post/30618/newcoronavirus-spreads-to-over-130-in-china-death-tollrises)</mark>. In addition, two patients in Thailand, one in Japan, and one in South Korea, were detected positive for 2019-nCoV"
        },
        {
            "participant": "patients",
            "number": 2,
            "context": "Among the 170 patients under treatment in hospitals, 126, 35, and 9 are in mild, severe, and critical condition, respectively (http://www.thatsmags.com/china/post/30618/newcoronavirus-spreads-to-over-130-in-china-death-tollrises). <mark class=\"stats\">In addition, two patients in Thailand, one in Japan, and one in South Korea, were detected positive for 2019-nCoV</mark>. They did not visit the specific seafood market, but might have close contact with some pneumonia patients during their trip in Wuhan, raising the concern of limited human-to-human transmission of 2019-nCoV (http://www.thatsmags.com/china/post/ 30618/new-coronavirus-spreads-to-over-130-inchina-death-toll-rises)"
        }
    ],
    "statistics": [
        {
            "tests": {
                "context": "<mark class=\"stats\">Analysis of the functional domains in 2019-nCoV spike protein and its gene. (A) Phylogenetic analysis of S gene of 2019nCoV (Wuhan-Hu-1), bat-SL-CoVZXC21, bat-SL-CoVZXC45, SARS-CoV and other coronaviruses using Neighbor-Joining method. (B) The representative scheme of functional domains in S protein of 2019-nCoV</mark>",
                "tests": [
                    {
                        "test": "Neighbor-Joining method"
                    }
                ]
            }
        }
    ],
    "keywords": [
        "MERS",
        "prophylactic strategy",
        "wild animal",
        "live animal",
        "coronavirus",
        "seafood market",
        "spike protein",
        "single seafood",
        "genomic characterization",
        "unknown aetiology",
        "SARS",
        "Rhinolopus sinicus",
        "fusion inhibitor",
        "novel coronavirus",
        "reverse transcription loop-mediated isothermal amplification",
        "fusion peptide",
        "monoclonal antibodies",
        "heptad repeat",
        "reverse transcription PCR",
        "receptor-binding domain",
        "N-terminal domain",
        "pneumonia outbreak"
    ],
    "keyword_relevance": {
        "coronavirus": 0.16911764705882354,
        "SARS": 0.13970588235294118,
        "heptad repeat": 0.11764705882352941,
        "receptor-binding domain": 0.11764705882352941,
        "MERS": 0.09558823529411764,
        "monoclonal antibodies": 0.04411764705882353,
        "N-terminal domain": 0.04411764705882353,
        "spike protein": 0.03676470588235294,
        "fusion peptide": 0.03676470588235294,
        "reverse transcription PCR": 0.03676470588235294,
        "seafood market": 0.029411764705882353,
        "live animal": 0.022058823529411766,
        "fusion inhibitor": 0.022058823529411766,
        "novel coronavirus": 0.022058823529411766,
        "pneumonia outbreak": 0.022058823529411766,
        "reverse transcription loop-mediated isothermal amplification": 0.014705882352941176,
        "wild animal": 0.007352941176470588,
        "single seafood": 0.007352941176470588,
        "unknown aetiology": 0.007352941176470588,
        "Rhinolopus sinicus": 0.007352941176470588,
        "prophylactic strategy": 0.0,
        "genomic characterization": 0.0
    },
    "species": [
        "Rhinolopus sinicus"
    ],
    "summary": [
        "An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.",
        "To cite this article: Shibo Jiang, Lanying Du & Zhengli Shi (2020) An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies, Emerging Microbes & Infections, 9:1, 275-277, DOI: 10.1080/22221751.2020.1723441",
        "Shibo Jiang a,b, Lanying Du b and Zhengli Shi c aKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, People\u2019s Republic of China; bLindsley F.",
        "ARTICLE HISTORY Received January 2020; Accepted January 2020 In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and some live animals, including poultry, bats, marmots and other wild animals, suggesting that the pathogen may be transmitted from an animal to human.",
        "The authors have recently designed and engineered a panCoV fusion inhibitor, EK1 peptide, which could inhibit infection of five human coronaviruses, including SARS-CoV and MERS-CoV, and three bat-SL-CoVs [<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>].",
        "Intranasal application of EK1 peptide before or after viral challenge, EK1 peptide can protect human DPP4-transgenic mice from MERS-CoV infection, suggesting its potential prophylactic and therapeutic effect against 2019-nCoV infection.",
        "The authors will develop EK1 peptide as a t prophylactic or therapeutic for intranasal application to prevent or treat infection by 2019-nCoV and other emerging coronaviruses in the future.",
        "The RBDs of SARS-CoV and MERS-CoV contain multiple conformation-dependent neutralizing epitopes that induce more potent neutralizing antibodies and protective efficacy against SARS-CoV and MERS-CoV infections, respectively, than other regions in S protein [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>,<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>].",
        "Modification of MERS-CoV S-RBD amino acid residues based on the structure design could improve its protection against MERS-CoV infection [<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>], suggesting that 2019-nCoV S-RBD or modified S-RBD of other coronavirus may be applied for developing 2019-nCoV vaccines.",
        "The recently developed SARS-CoV and MERS-CoV neutralizing monoclonal antibodies and nanobodies with protective efficacy are specific to the S1 subunit of S protein, the RBD [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>\u2013<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>].",
        "The 2019-nCoV S-RBD is anticipated to be a key target for developing 2019-nCoV neutralizing mAbs. The neutralizing mAbs targeting non-RBD regions, including NTD and S2 of SARS-CoV and/or MERS-CoV S could be identified [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>,<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>,<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>], their neutralizing potency is generally lower than that of RBD-specific mAbs. It may take several months or even years for researching and developing neutralizing antibodies against 2019-nCoV infection."
    ],
    "structured_summary": {
        "Introduction": [
            "An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.",
            "To cite this article: Shibo Jiang, Lanying Du & Zhengli Shi (2020) An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies, Emerging Microbes & Infections, 9:1, 275-277, DOI: 10.1080/22221751.2020.1723441"
        ],
        "Results": [
            "Shibo Jiang a,b, Lanying Du b and Zhengli Shi c aKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, People\u2019s Republic of China; bLindsley F.",
            "ARTICLE HISTORY Received January 2020; Accepted January 2020 In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and some live animals, including poultry, bats, marmots and other wild animals, suggesting that the pathogen may be transmitted from an animal to human.",
            "The authors have recently designed and engineered a panCoV fusion inhibitor, EK1 peptide, which could inhibit infection of five human coronaviruses, including SARS-CoV and MERS-CoV, and three bat-SL-CoVs [<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>].",
            "Intranasal application of EK1 peptide before or after viral challenge, EK1 peptide can protect human DPP4-transgenic mice from MERS-CoV infection, suggesting its potential prophylactic and therapeutic effect against 2019-nCoV infection.",
            "The authors will develop EK1 peptide as a t prophylactic or therapeutic for intranasal application to prevent or treat infection by 2019-nCoV and other emerging coronaviruses in the future.",
            "The RBDs of SARS-CoV and MERS-CoV contain multiple conformation-dependent neutralizing epitopes that induce more potent neutralizing antibodies and protective efficacy against SARS-CoV and MERS-CoV infections, respectively, than other regions in S protein [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>,<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>].",
            "Modification of MERS-CoV S-RBD amino acid residues based on the structure design could improve its protection against MERS-CoV infection [<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>], suggesting that 2019-nCoV S-RBD or modified S-RBD of other coronavirus may be applied for developing 2019-nCoV vaccines."
        ],
        "Conclusion": [
            "The recently developed SARS-CoV and MERS-CoV neutralizing monoclonal antibodies and nanobodies with protective efficacy are specific to the S1 subunit of S protein, the RBD [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>\u2013<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>].",
            "The 2019-nCoV S-RBD is anticipated to be a key target for developing 2019-nCoV neutralizing mAbs. The neutralizing mAbs targeting non-RBD regions, including NTD and S2 of SARS-CoV and/or MERS-CoV S could be identified [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>,<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>,<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>], their neutralizing potency is generally lower than that of RBD-specific mAbs. It may take several months or even years for researching and developing neutralizing antibodies against 2019-nCoV infection."
        ]
    },
    "reference_links": [
        {
            "id": "1",
            "alt_id": "Lu_et+al_0000_a",
            "entry": "[1] Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92. DOI:10.1002/jmv. 25678",
            "crossref": "https://dx.doi.org/10.1002/jmv.25678",
            "scite": "https://scite.ai/reports/10.1002/jmv.25678",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1002/jmv.25678"
        },
        {
            "id": "2",
            "alt_id": "Chan_et+al_2019_a",
            "entry": "[2] Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory disease in Wuhan, Hubei, China. Emerg Microbes Infect. 2020;9:221\u2013236.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chan%20JF%20Kok%20KH%20Zhu%20Z%20et%20al%20Genomic%20characterization%20of%20the%202019%20novel%20humanpathogenic%20coronavirus%20isolated%20from%20patients%20with%20acute%20respiratory%20disease%20in%20Wuhan%20Hubei%20China%20Emerg%20Microbes%20Infect%2020209221236",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chan%20JF%20Kok%20KH%20Zhu%20Z%20et%20al%20Genomic%20characterization%20of%20the%202019%20novel%20humanpathogenic%20coronavirus%20isolated%20from%20patients%20with%20acute%20respiratory%20disease%20in%20Wuhan%20Hubei%20China%20Emerg%20Microbes%20Infect%2020209221236",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chan%20JF%20Kok%20KH%20Zhu%20Z%20et%20al%20Genomic%20characterization%20of%20the%202019%20novel%20humanpathogenic%20coronavirus%20isolated%20from%20patients%20with%20acute%20respiratory%20disease%20in%20Wuhan%20Hubei%20China%20Emerg%20Microbes%20Infect%2020209221236"
        },
        {
            "id": "3",
            "alt_id": "Hu_et+al_2018_a",
            "entry": "[3] Hu D, Zhu C, Ai L, et al. Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerg Microbes Infect. 2018;7:154.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hu%2C%20D.%20Zhu%2C%20C.%20Ai%2C%20L.%20Genomic%20characterization%20and%20infectivity%20of%20a%20novel%20SARS-like%20coronavirus%20in%20Chinese%20bats%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hu%2C%20D.%20Zhu%2C%20C.%20Ai%2C%20L.%20Genomic%20characterization%20and%20infectivity%20of%20a%20novel%20SARS-like%20coronavirus%20in%20Chinese%20bats%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hu%2C%20D.%20Zhu%2C%20C.%20Ai%2C%20L.%20Genomic%20characterization%20and%20infectivity%20of%20a%20novel%20SARS-like%20coronavirus%20in%20Chinese%20bats%202018"
        },
        {
            "id": "4",
            "alt_id": "Zhang_et+al_0000_a",
            "entry": "[4] Zhang N, Wang L, Deng X, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92. DOI:10.1002/jmv.25674",
            "crossref": "https://dx.doi.org/10.1002/jmv.25674",
            "scite": "https://scite.ai/reports/10.1002/jmv.25674",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1002/jmv.25674"
        },
        {
            "id": "5",
            "alt_id": "Du_et+al_2009_a",
            "entry": "[5] Du L, He Y, Zhou Y, et al. The spike protein of SARSCoV\u2014a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7:226\u2013236.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Du%2C%20L.%20He%2C%20Y.%20Zhou%2C%20Y.%20The%20spike%20protein%20of%20SARSCoV%E2%80%94a%20target%20for%20vaccine%20and%20therapeutic%20development%202009",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Du%2C%20L.%20He%2C%20Y.%20Zhou%2C%20Y.%20The%20spike%20protein%20of%20SARSCoV%E2%80%94a%20target%20for%20vaccine%20and%20therapeutic%20development%202009",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Du%2C%20L.%20He%2C%20Y.%20Zhou%2C%20Y.%20The%20spike%20protein%20of%20SARSCoV%E2%80%94a%20target%20for%20vaccine%20and%20therapeutic%20development%202009"
        },
        {
            "id": "6",
            "alt_id": "Liu_et+al_2004_a",
            "entry": "[6] Liu S, Xiao G, Chen Y, et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARSassociated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet. 2004;363:938\u2013947.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Liu%2C%20S.%20Xiao%2C%20G.%20Chen%2C%20Y.%20Interaction%20between%20heptad%20repeat%201%20and%202%20regions%20in%20spike%20protein%20of%20SARSassociated%20coronavirus%3A%20implications%20for%20virus%20fusogenic%20mechanism%20and%20identification%20of%20fusion%20inhibitors%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Liu%2C%20S.%20Xiao%2C%20G.%20Chen%2C%20Y.%20Interaction%20between%20heptad%20repeat%201%20and%202%20regions%20in%20spike%20protein%20of%20SARSassociated%20coronavirus%3A%20implications%20for%20virus%20fusogenic%20mechanism%20and%20identification%20of%20fusion%20inhibitors%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Liu%2C%20S.%20Xiao%2C%20G.%20Chen%2C%20Y.%20Interaction%20between%20heptad%20repeat%201%20and%202%20regions%20in%20spike%20protein%20of%20SARSassociated%20coronavirus%3A%20implications%20for%20virus%20fusogenic%20mechanism%20and%20identification%20of%20fusion%20inhibitors%202004"
        },
        {
            "id": "7",
            "alt_id": "Xia_et+al_2019_a",
            "entry": "[7] Xia S, Yan L, Xu W, et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019;5:eaav4580.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Xia%2C%20S.%20Yan%2C%20L.%20Xu%2C%20W.%20A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Xia%2C%20S.%20Yan%2C%20L.%20Xu%2C%20W.%20A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Xia%2C%20S.%20Yan%2C%20L.%20Xu%2C%20W.%20A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike%202019"
        },
        {
            "id": "8",
            "alt_id": "Du_et+al_2017_a",
            "entry": "[8] Du L, Yang Y, Zhou Y, et al. MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets. 2017;21:131\u2013143.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Du%2C%20L.%20Yang%2C%20Y.%20Zhou%2C%20Y.%20MERS-CoV%20spike%20protein%3A%20a%20key%20target%20for%20antivirals.%20Expert%20Opin%20Ther%20Targets%202017"
        },
        {
            "id": "9",
            "alt_id": "Zhou_et+al_2019_a",
            "entry": "[9] Zhou Y, Yang Y, Huang J, et al. Advances in MERSCoV vaccines and therapeutics based on the receptor-binding domain. Viruses. 2019;11:pii: E60.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhou%2C%20Y.%20Yang%2C%20Y.%20Huang%2C%20J.%20Advances%20in%20MERSCoV%20vaccines%20and%20therapeutics%20based%20on%20the%20receptor-binding%20domain.%20Viruses%202019"
        },
        {
            "id": "10",
            "alt_id": "Du_et+al_2016_a",
            "entry": "[10] Du L, Tai W, Yang Y, et al. Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines. Nat Commun. 2016;7:13473.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Du%2C%20L.%20Tai%2C%20W.%20Yang%2C%20Y.%20Introduction%20of%20neutralizing%20immunogenicity%20index%20to%20the%20rational%20design%20of%20MERS%20coronavirus%20subunit%20vaccines%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Du%2C%20L.%20Tai%2C%20W.%20Yang%2C%20Y.%20Introduction%20of%20neutralizing%20immunogenicity%20index%20to%20the%20rational%20design%20of%20MERS%20coronavirus%20subunit%20vaccines%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Du%2C%20L.%20Tai%2C%20W.%20Yang%2C%20Y.%20Introduction%20of%20neutralizing%20immunogenicity%20index%20to%20the%20rational%20design%20of%20MERS%20coronavirus%20subunit%20vaccines%202016"
        },
        {
            "id": "11",
            "alt_id": "Wang_et+al_2015_a",
            "entry": "[11] Wang L, Shi W, Joyce MG, et al. Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6:7712.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%2C%20L.%20Shi%2C%20W.%20Joyce%2C%20M.G.%20Evaluation%20of%20candidate%20vaccine%20approaches%20for%20MERS-CoV%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wang%2C%20L.%20Shi%2C%20W.%20Joyce%2C%20M.G.%20Evaluation%20of%20candidate%20vaccine%20approaches%20for%20MERS-CoV%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wang%2C%20L.%20Shi%2C%20W.%20Joyce%2C%20M.G.%20Evaluation%20of%20candidate%20vaccine%20approaches%20for%20MERS-CoV%202015"
        },
        {
            "id": "12",
            "alt_id": "Chen_et+al_2017_a",
            "entry": "[12] Chen Y, Lu S, Jia H, et al. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017;6:e37.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chen%2C%20Y.%20Lu%2C%20S.%20Jia%2C%20H.%20A%20novel%20neutralizing%20monoclonal%20antibody%20targeting%20the%20N-terminal%20domain%20of%20the%20MERS-CoV%20spike%20protein%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chen%2C%20Y.%20Lu%2C%20S.%20Jia%2C%20H.%20A%20novel%20neutralizing%20monoclonal%20antibody%20targeting%20the%20N-terminal%20domain%20of%20the%20MERS-CoV%20spike%20protein%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chen%2C%20Y.%20Lu%2C%20S.%20Jia%2C%20H.%20A%20novel%20neutralizing%20monoclonal%20antibody%20targeting%20the%20N-terminal%20domain%20of%20the%20MERS-CoV%20spike%20protein%202017"
        },
        {
            "id": "13",
            "alt_id": "Zeng_et+al_2017_a",
            "entry": "[13] Zeng LP, Ge X-Y, Peng C, et al. Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. Sci China Life Sci. 2017;60:1399\u20131402. ",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zeng%2C%20L.P.%20Ge%2C%20X.-Y.%20Peng%2C%20C.%20Cross-neutralization%20of%20SARS%20coronavirus-specific%20antibodies%20against%20bat%20SARS-like%20coronaviruses%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zeng%2C%20L.P.%20Ge%2C%20X.-Y.%20Peng%2C%20C.%20Cross-neutralization%20of%20SARS%20coronavirus-specific%20antibodies%20against%20bat%20SARS-like%20coronaviruses%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zeng%2C%20L.P.%20Ge%2C%20X.-Y.%20Peng%2C%20C.%20Cross-neutralization%20of%20SARS%20coronavirus-specific%20antibodies%20against%20bat%20SARS-like%20coronaviruses%202017"
        }
    ],
    "facts": [
        "an outbreak of pneumonia caused by an unknown aetiology occurred in",
        "most patients were linked to a single seafood market",
        "that the pathogen may be transmitted from an animal to human",
        "Modification of MERS-CoV S-RBD amino acid residues based on the structure design could improve its protection against MERS-CoV infection",
        "MERS-CoV neutralizing monoclonal antibodies and nanobodies with protective efficacy are specific to the S1 subunit of S protein",
        "The neutralizing mAbs targeting non-RBD regions"
    ],
    "claims": [
        "We have shown that SARS-CoV S-RBD-specific neutralizing mAbs and sera could cross-neutralize bat-SL-CoVs, such as bat-SL-CoV-W1V1 and bat-SL-"
    ],
    "findings": [],
    "processes": [],
    "key_statements": [
        "ARTICLE HISTORY Received January 2020; Accepted January 2020 In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and some live animals, including poultry, bats, marmots and other wild animals, suggesting that the pathogen may be transmitted from an animal to human",
        "Modification of MERS-CoV S-receptor-binding domain amino acid residues based on the structure design could improve its protection against MERS-CoV infection [<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>], suggesting that 2019-nCoV S-receptor-binding domain or modified S-receptor-binding domain of other coronavirus may be applied for developing 2019-nCoV vaccines",
        "The neutralizing monoclonal antibodies targeting non-receptor-binding domain regions, including N-terminal domain and S2 of SARS-CoV and/or MERS-CoV S could be identified [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>,<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>,<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>], their neutralizing potency is generally lower than that of receptor-binding domain-specific monoclonal antibodies",
        "We have shown that SARS-CoV S-receptor-binding domain-specific neutralizing monoclonal antibodies and sera could cross-neutralize bat-SL-CoVs, such as bat-SL-CoV-W1V1 and bat-SL-"
    ],
    "top_statements": [
        "An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies",
        "ARTICLE HISTORY Received January 2020; Accepted January 2020 In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and some live animals, including poultry, bats, marmots and other wild animals, suggesting that the pathogen may be transmitted from an animal to human",
        "Modification of MERS-CoV S-receptor-binding domain amino acid residues based on the structure design could improve its protection against MERS-CoV infection [<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>], suggesting that 2019-nCoV S-receptor-binding domain or modified S-receptor-binding domain of other coronavirus may be applied for developing 2019-nCoV vaccines",
        "The neutralizing monoclonal antibodies targeting non-receptor-binding domain regions, including N-terminal domain and S2 of SARS-CoV and/or MERS-CoV S could be identified [<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>,<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>,<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>], their neutralizing potency is generally lower than that of receptor-binding domain-specific monoclonal antibodies",
        "We have shown that SARS-CoV S-receptor-binding domain-specific neutralizing monoclonal antibodies and sera could cross-neutralize bat-SL-CoVs, such as bat-SL-CoV-W1V1 and bat-SL-"
    ],
    "headline": "ARTICLE HISTORY Received January 2020; Accepted January 2020 In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly sold seafood and some live animals, including poultry, bats, marmots and other wild animals, suggesting that the pathogen may be transmitted from an animal to human",
    "contexts": [],
    "abbreviations": {
        "RT-PCR": "reverse transcription PCR",
        "rRT-PCR": "reverse transcription PCR",
        "RT-LAMP": "reverse transcription loop-mediated isothermal amplification",
        "NTD": "N-terminal domain",
        "RBD": "receptor-binding domain",
        "FP": "fusion peptide",
        "HR": "heptad repeat",
        "mAbs": "monoclonal antibodies"
    }
}
